KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Equity Average (2016 - 2025)

Historic Equity Average for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $28.0 billion.

  • Cme's Equity Average rose 13.84% to $28.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 billion, marking a year-over-year increase of 13.84%. This contributed to the annual value of $26.6 billion for FY2024, which is 73.07% down from last year.
  • As of Q3 2025, Cme's Equity Average stood at $28.0 billion, which was up 13.84% from $27.4 billion recorded in Q2 2025.
  • Cme's Equity Average's 5-year high stood at $28.1 billion during Q3 2022, with a 5-year trough of $26.4 billion in Q1 2021.
  • Its 5-year average for Equity Average is $27.4 billion, with a median of $27.4 billion in 2024.
  • As far as peak fluctuations go, Cme's Equity Average surged by 449.02% in 2022, and later crashed by 158.34% in 2023.
  • Cme's Equity Average (Quarter) stood at $27.3 billion in 2021, then rose by 0.82% to $27.6 billion in 2022, then dropped by 0.44% to $27.4 billion in 2023, then decreased by 0.34% to $27.4 billion in 2024, then rose by 2.24% to $28.0 billion in 2025.
  • Its last three reported values are $28.0 billion in Q3 2025, $27.4 billion for Q2 2025, and $26.8 billion during Q1 2025.